Key Insights
The veterinary oncology market is experiencing significant expansion, propelled by heightened pet ownership, growing pet humanization trends, and advancements in cancer treatment modalities. The market is projected to grow at a Compound Annual Growth Rate (CAGR) of 11.8%. As of the base year 2025, the market size was valued at 810.5 million. Key growth drivers include the increasing incidence of cancers such as lymphoma, mast cell tumors, and mammary tumors in canine and feline populations, alongside a growing owner willingness to invest in advanced care. Treatment modalities like radiotherapy, surgery, and chemotherapy are primary revenue generators, with radiotherapy and surgery anticipated to maintain substantial market shares due to their proven efficacy. Future growth will be further stimulated by the introduction of innovative therapies, targeted drug development, and enhanced diagnostic capabilities. However, market growth may be tempered by high treatment costs, limited access to specialized veterinary oncologists in certain regions, and ethical considerations surrounding advanced-stage cancer treatment choices. Geographically, North America and Europe currently dominate, supported by high pet ownership and developed healthcare infrastructure. The Asia-Pacific region is poised for substantial growth, driven by rising pet adoption and economic development.
Veterinary Oncology Market Market Size (In Million)
The competitive environment features established pharmaceutical giants such as Zoetis and Elanco, alongside specialized veterinary oncology providers including PetCure Oncology and Morphogenesis. These entities are prioritizing the development of novel therapeutics, portfolio expansion, and market penetration through strategic alliances and acquisitions. Sustained market expansion is contingent upon successful research and development initiatives, regulatory approvals for new treatments, and enhanced collaboration among veterinary oncologists, researchers, and pharmaceutical firms. Continued innovation in targeted therapies, immunotherapy, and personalized medicine will be crucial for broadening treatment options and improving patient outcomes, thereby driving future market growth. The market's trajectory suggests increasing consolidation and heightened competition among key players, fostering further innovation and striving for more accessible and affordable veterinary cancer care.
Veterinary Oncology Market Company Market Share
Veterinary Oncology Market: Comprehensive Report 2019-2033
This in-depth report provides a comprehensive analysis of the Veterinary Oncology Market from 2019 to 2033, offering invaluable insights for industry professionals, investors, and researchers. The study period covers the historical period (2019-2024), the base year (2025), and the forecast period (2025-2033). The report segments the market by application, treatment type, and animal type, providing detailed analysis and projections for each segment. Key players such as Morphogenesis Inc, Elanco, and Zoetis Inc. are profiled, highlighting their market strategies and contributions to innovation. Download now to gain a competitive edge in this rapidly expanding market.
Veterinary Oncology Market Structure & Innovation Trends
The Veterinary Oncology market is characterized by a moderately concentrated structure with several key players holding significant market share. While precise market share data for each company is proprietary and varies by segment, key players like Zoetis Inc. and Elanco hold substantial positions. The market is experiencing considerable innovation driven by advancements in targeted therapies, improved diagnostic tools (such as advanced imaging), and personalized medicine approaches. Regulatory frameworks, varying across different geographies, play a crucial role in market access and product approvals. Substitutes for current treatments are limited, though advancements in immunotherapy and other novel therapeutic modalities represent potential future competition. End-user demographics are expanding as pet ownership and pet humanization trends continue to increase. M&A activity within the sector has been moderate, with deal values fluctuating based on the size and strategic importance of the acquired companies. Some examples of past M&A activities are difficult to ascertain without proprietary data, but the expectation is that xx Million dollars were involved in such activities in the last 5 years.
- Market Concentration: Moderately concentrated, with several dominant players.
- Innovation Drivers: Advanced therapies, improved diagnostics, personalized medicine.
- Regulatory Frameworks: Varying by geography; impacting product approvals and market access.
- Product Substitutes: Currently limited, but evolving with immunotherapy and other novel therapies.
- End-User Demographics: Growing due to increased pet ownership and humanization trends.
- M&A Activity: Moderate activity, with deal values varying based on the deal size.
Veterinary Oncology Market Dynamics & Trends
The Veterinary Oncology market is experiencing robust growth, projected to achieve a CAGR of xx% during the forecast period (2025-2033). This growth is fueled by several factors, including increasing pet ownership and longevity, rising pet healthcare expenditure, growing awareness of pet cancer, and technological advancements leading to improved diagnostics and treatment options. Technological disruptions, such as the development of more precise radiation therapy and advanced imaging techniques, are driving market expansion. Consumer preferences are shifting towards more personalized and less invasive treatments, creating opportunities for innovative solutions. The competitive landscape is dynamic, with existing players constantly innovating and new entrants emerging with disruptive technologies. Market penetration of advanced treatment options remains relatively low, suggesting significant growth potential.
Dominant Regions & Segments in Veterinary Oncology Market
North America currently dominates the Veterinary Oncology market, driven by high pet ownership rates, advanced healthcare infrastructure, and higher disposable incomes. Europe follows as a significant market, while Asia-Pacific shows promising growth potential due to increasing pet ownership and economic development.
By Application:
- Lymphoma Cancer: This segment holds a significant market share due to its high prevalence in companion animals.
- Mast Cell Cancer: This represents a substantial segment due to its prevalence and the need for specialized treatment.
- Mammary and Squamous Cell Cancer: This segment is growing consistently due to increased detection rates and advanced treatment modalities.
- Other Applications: This segment comprises various cancers with relatively lower prevalence.
By Treatment Type:
- Chemotherapy: Remains a dominant treatment modality due to its established efficacy across a range of cancers.
- Surgery: Significant market share due to its effectiveness in localized cancers.
- Radiotherapy: Growing steadily with advancements in radiation technology providing more targeted treatment options.
- Other Treatment Types: This includes emerging therapies like immunotherapy, which are gaining traction.
By Animal Type:
- Canine: This segment dominates the market due to the higher prevalence of cancer in dogs compared to other animals.
- Feline: Represents a substantial segment, driven by increased feline life expectancy and cancer detection.
- Other Animal Types: This comprises a relatively smaller segment encompassing other companion animals.
Key Drivers (by region):
- North America: High pet ownership, advanced healthcare infrastructure, high disposable incomes.
- Europe: High pet ownership, robust veterinary infrastructure, increasing pet insurance coverage.
- Asia-Pacific: Growing pet ownership, increasing disposable incomes, improving healthcare infrastructure.
Veterinary Oncology Market Product Innovations
Recent product innovations include advanced radiotherapy systems offering greater precision and reduced side effects, novel chemotherapeutic agents with improved efficacy and reduced toxicity, and diagnostic tools allowing for earlier and more accurate cancer detection. These innovations are improving treatment outcomes and addressing the unmet needs of both veterinarians and pet owners. The market is witnessing a shift towards personalized medicine approaches, with treatments tailored to the specific genetic makeup of the tumor. This focus on precision medicine is improving treatment effectiveness and minimizing adverse effects.
Report Scope & Segmentation Analysis
This report comprehensively analyzes the Veterinary Oncology market, segmented by application (Lymphoma Cancer, Mast Cell Cancer, Mammary and Squamous Cell Cancer, Other Applications), treatment type (Radiotherapy, Surgery, Chemotherapy, Other Treatment Types), and animal type (Canine, Feline, Other Animal Types). Each segment's growth projections, market sizes, and competitive dynamics are detailed within the full report. For example, the Canine segment is projected to dominate due to higher cancer incidence rates, while Lymphoma Cancer is expected to be a leading application segment. Growth rates vary across segments depending on prevalence, treatment advancements, and economic factors.
Key Drivers of Veterinary Oncology Market Growth
Several factors contribute to the market's growth. Increasing pet ownership globally fuels demand for veterinary services. Rising disposable incomes enable pet owners to afford advanced cancer treatments. Technological advancements, such as improved diagnostic imaging and targeted therapies, enhance treatment efficacy. Growing awareness of pet cancer and the human-animal bond motivates pet owners to seek advanced care. Furthermore, favorable regulatory environments in several regions facilitate market expansion.
Challenges in the Veterinary Oncology Market Sector
The Veterinary Oncology market faces challenges including the high cost of advanced treatments, which may limit accessibility for some pet owners. Regulatory hurdles and varying approval processes across different regions pose obstacles to market entry for new products. Supply chain disruptions, particularly impacting specialized medications and equipment, can impact market availability. Intense competition among existing players and emerging innovative technologies create pressure on pricing and market share. The xx Million dollar investment in research and development points to the need for more funding to support the growth and innovation within the sector.
Emerging Opportunities in Veterinary Oncology Market
Emerging opportunities include the development of novel targeted therapies, immunotherapy, and other advanced treatment modalities. The increasing use of telemedicine and remote monitoring offers potential for improved patient care and access to specialized services. Growing interest in personalized medicine and companion diagnostics provides opportunities for customized treatment strategies. Expansion into emerging markets with growing pet ownership presents significant growth potential. Further investment in research and development will unlock opportunities in this growing market.
Leading Players in the Veterinary Oncology Market
- Morphogenesis Inc
- Elanco
- OHC (One Health Company)
- Karyopharm
- Siemens Healthineers (Varian Medical System Inc)
- Boehringer Ingelheim International GmbH
- Accuray Incorporated
- Regeneus Ltd
- AB Science
- Nippon Zenyaku Kogyo Co Ltd (ZENOAQ)
- PetCure Oncology
- Zoetis Inc
Key Developments in Veterinary Oncology Market Industry
- November 2022: The UW School of Veterinary Medicine received a USD 75,000 grant to provide life-saving cancer care to pets, highlighting the increasing focus on accessibility of treatment.
- May 2022: Jaguar Health launched the Canine Cancer: Take C.H.A.R.G.E. registry, enhancing data collection and improving diagnostic and treatment decisions in canine cancer. This initiative improved data availability, benefiting the industry and researchers.
Future Outlook for Veterinary Oncology Market
The Veterinary Oncology market exhibits substantial growth potential driven by several factors including advancements in cancer therapies, increased pet ownership, and rising pet healthcare expenditure. Strategic opportunities lie in developing innovative treatment options, expanding into emerging markets, and leveraging technological advancements to improve access to care. The market is poised for continued growth, offering significant prospects for industry stakeholders.
Veterinary Oncology Market Segmentation
-
1. Treatment Type
- 1.1. Radiotherapy
- 1.2. Surgery
- 1.3. Chemotherapy
- 1.4. Other Treatment Types
-
2. Animal Type
- 2.1. Canine
- 2.2. Feline
- 2.3. Other Animal Types
-
3. Application
- 3.1. Lymphoma Cancer
- 3.2. Mast Cell Cancer
- 3.3. Mammary and Squamous Cell Cancer
- 3.4. Other Applications
Veterinary Oncology Market Segmentation By Geography
-
1. North America
- 1.1. United States
- 1.2. Canada
- 1.3. Mexico
-
2. Europe
- 2.1. Germany
- 2.2. United Kingdom
- 2.3. France
- 2.4. Spain
- 2.5. Italy
- 2.6. Rest of Europe
-
3. Asia Pacific
- 3.1. China
- 3.2. Japan
- 3.3. India
- 3.4. Australia
- 3.5. South Korea
- 3.6. Rest of Asia Pacific
-
4. Middle East and Africa
- 4.1. GCC
- 4.2. South Africa
- 4.3. Rest of Middle East and Africa
-
5. South America
- 5.1. Brazil
- 5.2. Argentina
- 5.3. Rest of South America
Veterinary Oncology Market Regional Market Share
Geographic Coverage of Veterinary Oncology Market
Veterinary Oncology Market REPORT HIGHLIGHTS
| Aspects | Details |
|---|---|
| Study Period | 2020-2034 |
| Base Year | 2025 |
| Estimated Year | 2026 |
| Forecast Period | 2026-2034 |
| Historical Period | 2020-2025 |
| Growth Rate | CAGR of 11.8% from 2020-2034 |
| Segmentation |
|
Table of Contents
- 1. Introduction
- 1.1. Research Scope
- 1.2. Market Segmentation
- 1.3. Research Methodology
- 1.4. Definitions and Assumptions
- 2. Executive Summary
- 2.1. Introduction
- 3. Market Dynamics
- 3.1. Introduction
- 3.2. Market Drivers
- 3.2.1. Rising Prevalence of Cancer Cases in Animals; Increasing Investment on Research and Development in the Area of Veterinary Oncology
- 3.3. Market Restrains
- 3.3.1. High Cost of Cancer Treatment and Procedures; Lack of Awareness About Veterinary Diseases Among Owners
- 3.4. Market Trends
- 3.4.1. Canine Animal Type Segment is Expected to Hold a Significant Share in the Market Over the Forecast Period
- 4. Market Factor Analysis
- 4.1. Porters Five Forces
- 4.2. Supply/Value Chain
- 4.3. PESTEL analysis
- 4.4. Market Entropy
- 4.5. Patent/Trademark Analysis
- 5. Global Veterinary Oncology Market Analysis, Insights and Forecast, 2020-2032
- 5.1. Market Analysis, Insights and Forecast - by Treatment Type
- 5.1.1. Radiotherapy
- 5.1.2. Surgery
- 5.1.3. Chemotherapy
- 5.1.4. Other Treatment Types
- 5.2. Market Analysis, Insights and Forecast - by Animal Type
- 5.2.1. Canine
- 5.2.2. Feline
- 5.2.3. Other Animal Types
- 5.3. Market Analysis, Insights and Forecast - by Application
- 5.3.1. Lymphoma Cancer
- 5.3.2. Mast Cell Cancer
- 5.3.3. Mammary and Squamous Cell Cancer
- 5.3.4. Other Applications
- 5.4. Market Analysis, Insights and Forecast - by Region
- 5.4.1. North America
- 5.4.2. Europe
- 5.4.3. Asia Pacific
- 5.4.4. Middle East and Africa
- 5.4.5. South America
- 5.1. Market Analysis, Insights and Forecast - by Treatment Type
- 6. North America Veterinary Oncology Market Analysis, Insights and Forecast, 2020-2032
- 6.1. Market Analysis, Insights and Forecast - by Treatment Type
- 6.1.1. Radiotherapy
- 6.1.2. Surgery
- 6.1.3. Chemotherapy
- 6.1.4. Other Treatment Types
- 6.2. Market Analysis, Insights and Forecast - by Animal Type
- 6.2.1. Canine
- 6.2.2. Feline
- 6.2.3. Other Animal Types
- 6.3. Market Analysis, Insights and Forecast - by Application
- 6.3.1. Lymphoma Cancer
- 6.3.2. Mast Cell Cancer
- 6.3.3. Mammary and Squamous Cell Cancer
- 6.3.4. Other Applications
- 6.1. Market Analysis, Insights and Forecast - by Treatment Type
- 7. Europe Veterinary Oncology Market Analysis, Insights and Forecast, 2020-2032
- 7.1. Market Analysis, Insights and Forecast - by Treatment Type
- 7.1.1. Radiotherapy
- 7.1.2. Surgery
- 7.1.3. Chemotherapy
- 7.1.4. Other Treatment Types
- 7.2. Market Analysis, Insights and Forecast - by Animal Type
- 7.2.1. Canine
- 7.2.2. Feline
- 7.2.3. Other Animal Types
- 7.3. Market Analysis, Insights and Forecast - by Application
- 7.3.1. Lymphoma Cancer
- 7.3.2. Mast Cell Cancer
- 7.3.3. Mammary and Squamous Cell Cancer
- 7.3.4. Other Applications
- 7.1. Market Analysis, Insights and Forecast - by Treatment Type
- 8. Asia Pacific Veterinary Oncology Market Analysis, Insights and Forecast, 2020-2032
- 8.1. Market Analysis, Insights and Forecast - by Treatment Type
- 8.1.1. Radiotherapy
- 8.1.2. Surgery
- 8.1.3. Chemotherapy
- 8.1.4. Other Treatment Types
- 8.2. Market Analysis, Insights and Forecast - by Animal Type
- 8.2.1. Canine
- 8.2.2. Feline
- 8.2.3. Other Animal Types
- 8.3. Market Analysis, Insights and Forecast - by Application
- 8.3.1. Lymphoma Cancer
- 8.3.2. Mast Cell Cancer
- 8.3.3. Mammary and Squamous Cell Cancer
- 8.3.4. Other Applications
- 8.1. Market Analysis, Insights and Forecast - by Treatment Type
- 9. Middle East and Africa Veterinary Oncology Market Analysis, Insights and Forecast, 2020-2032
- 9.1. Market Analysis, Insights and Forecast - by Treatment Type
- 9.1.1. Radiotherapy
- 9.1.2. Surgery
- 9.1.3. Chemotherapy
- 9.1.4. Other Treatment Types
- 9.2. Market Analysis, Insights and Forecast - by Animal Type
- 9.2.1. Canine
- 9.2.2. Feline
- 9.2.3. Other Animal Types
- 9.3. Market Analysis, Insights and Forecast - by Application
- 9.3.1. Lymphoma Cancer
- 9.3.2. Mast Cell Cancer
- 9.3.3. Mammary and Squamous Cell Cancer
- 9.3.4. Other Applications
- 9.1. Market Analysis, Insights and Forecast - by Treatment Type
- 10. South America Veterinary Oncology Market Analysis, Insights and Forecast, 2020-2032
- 10.1. Market Analysis, Insights and Forecast - by Treatment Type
- 10.1.1. Radiotherapy
- 10.1.2. Surgery
- 10.1.3. Chemotherapy
- 10.1.4. Other Treatment Types
- 10.2. Market Analysis, Insights and Forecast - by Animal Type
- 10.2.1. Canine
- 10.2.2. Feline
- 10.2.3. Other Animal Types
- 10.3. Market Analysis, Insights and Forecast - by Application
- 10.3.1. Lymphoma Cancer
- 10.3.2. Mast Cell Cancer
- 10.3.3. Mammary and Squamous Cell Cancer
- 10.3.4. Other Applications
- 10.1. Market Analysis, Insights and Forecast - by Treatment Type
- 11. Competitive Analysis
- 11.1. Global Market Share Analysis 2025
- 11.2. Company Profiles
- 11.2.1 Morphogenesis Inc
- 11.2.1.1. Overview
- 11.2.1.2. Products
- 11.2.1.3. SWOT Analysis
- 11.2.1.4. Recent Developments
- 11.2.1.5. Financials (Based on Availability)
- 11.2.2 Elanco
- 11.2.2.1. Overview
- 11.2.2.2. Products
- 11.2.2.3. SWOT Analysis
- 11.2.2.4. Recent Developments
- 11.2.2.5. Financials (Based on Availability)
- 11.2.3 OHC (One Health Company)
- 11.2.3.1. Overview
- 11.2.3.2. Products
- 11.2.3.3. SWOT Analysis
- 11.2.3.4. Recent Developments
- 11.2.3.5. Financials (Based on Availability)
- 11.2.4 Karyopharm
- 11.2.4.1. Overview
- 11.2.4.2. Products
- 11.2.4.3. SWOT Analysis
- 11.2.4.4. Recent Developments
- 11.2.4.5. Financials (Based on Availability)
- 11.2.5 Siemens Healthineers (Varian Medical System Inc )
- 11.2.5.1. Overview
- 11.2.5.2. Products
- 11.2.5.3. SWOT Analysis
- 11.2.5.4. Recent Developments
- 11.2.5.5. Financials (Based on Availability)
- 11.2.6 Boehringer Ingelheim International GmbH
- 11.2.6.1. Overview
- 11.2.6.2. Products
- 11.2.6.3. SWOT Analysis
- 11.2.6.4. Recent Developments
- 11.2.6.5. Financials (Based on Availability)
- 11.2.7 Accuray Incorporated
- 11.2.7.1. Overview
- 11.2.7.2. Products
- 11.2.7.3. SWOT Analysis
- 11.2.7.4. Recent Developments
- 11.2.7.5. Financials (Based on Availability)
- 11.2.8 Regeneus Ltd
- 11.2.8.1. Overview
- 11.2.8.2. Products
- 11.2.8.3. SWOT Analysis
- 11.2.8.4. Recent Developments
- 11.2.8.5. Financials (Based on Availability)
- 11.2.9 AB Science
- 11.2.9.1. Overview
- 11.2.9.2. Products
- 11.2.9.3. SWOT Analysis
- 11.2.9.4. Recent Developments
- 11.2.9.5. Financials (Based on Availability)
- 11.2.10 Nippon Zenyaku Kogyo Co Ltd (ZENOAQ)
- 11.2.10.1. Overview
- 11.2.10.2. Products
- 11.2.10.3. SWOT Analysis
- 11.2.10.4. Recent Developments
- 11.2.10.5. Financials (Based on Availability)
- 11.2.11 PetCure Oncology
- 11.2.11.1. Overview
- 11.2.11.2. Products
- 11.2.11.3. SWOT Analysis
- 11.2.11.4. Recent Developments
- 11.2.11.5. Financials (Based on Availability)
- 11.2.12 Zoetis Inc
- 11.2.12.1. Overview
- 11.2.12.2. Products
- 11.2.12.3. SWOT Analysis
- 11.2.12.4. Recent Developments
- 11.2.12.5. Financials (Based on Availability)
- 11.2.1 Morphogenesis Inc
List of Figures
- Figure 1: Global Veterinary Oncology Market Revenue Breakdown (million, %) by Region 2025 & 2033
- Figure 2: North America Veterinary Oncology Market Revenue (million), by Treatment Type 2025 & 2033
- Figure 3: North America Veterinary Oncology Market Revenue Share (%), by Treatment Type 2025 & 2033
- Figure 4: North America Veterinary Oncology Market Revenue (million), by Animal Type 2025 & 2033
- Figure 5: North America Veterinary Oncology Market Revenue Share (%), by Animal Type 2025 & 2033
- Figure 6: North America Veterinary Oncology Market Revenue (million), by Application 2025 & 2033
- Figure 7: North America Veterinary Oncology Market Revenue Share (%), by Application 2025 & 2033
- Figure 8: North America Veterinary Oncology Market Revenue (million), by Country 2025 & 2033
- Figure 9: North America Veterinary Oncology Market Revenue Share (%), by Country 2025 & 2033
- Figure 10: Europe Veterinary Oncology Market Revenue (million), by Treatment Type 2025 & 2033
- Figure 11: Europe Veterinary Oncology Market Revenue Share (%), by Treatment Type 2025 & 2033
- Figure 12: Europe Veterinary Oncology Market Revenue (million), by Animal Type 2025 & 2033
- Figure 13: Europe Veterinary Oncology Market Revenue Share (%), by Animal Type 2025 & 2033
- Figure 14: Europe Veterinary Oncology Market Revenue (million), by Application 2025 & 2033
- Figure 15: Europe Veterinary Oncology Market Revenue Share (%), by Application 2025 & 2033
- Figure 16: Europe Veterinary Oncology Market Revenue (million), by Country 2025 & 2033
- Figure 17: Europe Veterinary Oncology Market Revenue Share (%), by Country 2025 & 2033
- Figure 18: Asia Pacific Veterinary Oncology Market Revenue (million), by Treatment Type 2025 & 2033
- Figure 19: Asia Pacific Veterinary Oncology Market Revenue Share (%), by Treatment Type 2025 & 2033
- Figure 20: Asia Pacific Veterinary Oncology Market Revenue (million), by Animal Type 2025 & 2033
- Figure 21: Asia Pacific Veterinary Oncology Market Revenue Share (%), by Animal Type 2025 & 2033
- Figure 22: Asia Pacific Veterinary Oncology Market Revenue (million), by Application 2025 & 2033
- Figure 23: Asia Pacific Veterinary Oncology Market Revenue Share (%), by Application 2025 & 2033
- Figure 24: Asia Pacific Veterinary Oncology Market Revenue (million), by Country 2025 & 2033
- Figure 25: Asia Pacific Veterinary Oncology Market Revenue Share (%), by Country 2025 & 2033
- Figure 26: Middle East and Africa Veterinary Oncology Market Revenue (million), by Treatment Type 2025 & 2033
- Figure 27: Middle East and Africa Veterinary Oncology Market Revenue Share (%), by Treatment Type 2025 & 2033
- Figure 28: Middle East and Africa Veterinary Oncology Market Revenue (million), by Animal Type 2025 & 2033
- Figure 29: Middle East and Africa Veterinary Oncology Market Revenue Share (%), by Animal Type 2025 & 2033
- Figure 30: Middle East and Africa Veterinary Oncology Market Revenue (million), by Application 2025 & 2033
- Figure 31: Middle East and Africa Veterinary Oncology Market Revenue Share (%), by Application 2025 & 2033
- Figure 32: Middle East and Africa Veterinary Oncology Market Revenue (million), by Country 2025 & 2033
- Figure 33: Middle East and Africa Veterinary Oncology Market Revenue Share (%), by Country 2025 & 2033
- Figure 34: South America Veterinary Oncology Market Revenue (million), by Treatment Type 2025 & 2033
- Figure 35: South America Veterinary Oncology Market Revenue Share (%), by Treatment Type 2025 & 2033
- Figure 36: South America Veterinary Oncology Market Revenue (million), by Animal Type 2025 & 2033
- Figure 37: South America Veterinary Oncology Market Revenue Share (%), by Animal Type 2025 & 2033
- Figure 38: South America Veterinary Oncology Market Revenue (million), by Application 2025 & 2033
- Figure 39: South America Veterinary Oncology Market Revenue Share (%), by Application 2025 & 2033
- Figure 40: South America Veterinary Oncology Market Revenue (million), by Country 2025 & 2033
- Figure 41: South America Veterinary Oncology Market Revenue Share (%), by Country 2025 & 2033
List of Tables
- Table 1: Global Veterinary Oncology Market Revenue million Forecast, by Treatment Type 2020 & 2033
- Table 2: Global Veterinary Oncology Market Revenue million Forecast, by Animal Type 2020 & 2033
- Table 3: Global Veterinary Oncology Market Revenue million Forecast, by Application 2020 & 2033
- Table 4: Global Veterinary Oncology Market Revenue million Forecast, by Region 2020 & 2033
- Table 5: Global Veterinary Oncology Market Revenue million Forecast, by Treatment Type 2020 & 2033
- Table 6: Global Veterinary Oncology Market Revenue million Forecast, by Animal Type 2020 & 2033
- Table 7: Global Veterinary Oncology Market Revenue million Forecast, by Application 2020 & 2033
- Table 8: Global Veterinary Oncology Market Revenue million Forecast, by Country 2020 & 2033
- Table 9: United States Veterinary Oncology Market Revenue (million) Forecast, by Application 2020 & 2033
- Table 10: Canada Veterinary Oncology Market Revenue (million) Forecast, by Application 2020 & 2033
- Table 11: Mexico Veterinary Oncology Market Revenue (million) Forecast, by Application 2020 & 2033
- Table 12: Global Veterinary Oncology Market Revenue million Forecast, by Treatment Type 2020 & 2033
- Table 13: Global Veterinary Oncology Market Revenue million Forecast, by Animal Type 2020 & 2033
- Table 14: Global Veterinary Oncology Market Revenue million Forecast, by Application 2020 & 2033
- Table 15: Global Veterinary Oncology Market Revenue million Forecast, by Country 2020 & 2033
- Table 16: Germany Veterinary Oncology Market Revenue (million) Forecast, by Application 2020 & 2033
- Table 17: United Kingdom Veterinary Oncology Market Revenue (million) Forecast, by Application 2020 & 2033
- Table 18: France Veterinary Oncology Market Revenue (million) Forecast, by Application 2020 & 2033
- Table 19: Spain Veterinary Oncology Market Revenue (million) Forecast, by Application 2020 & 2033
- Table 20: Italy Veterinary Oncology Market Revenue (million) Forecast, by Application 2020 & 2033
- Table 21: Rest of Europe Veterinary Oncology Market Revenue (million) Forecast, by Application 2020 & 2033
- Table 22: Global Veterinary Oncology Market Revenue million Forecast, by Treatment Type 2020 & 2033
- Table 23: Global Veterinary Oncology Market Revenue million Forecast, by Animal Type 2020 & 2033
- Table 24: Global Veterinary Oncology Market Revenue million Forecast, by Application 2020 & 2033
- Table 25: Global Veterinary Oncology Market Revenue million Forecast, by Country 2020 & 2033
- Table 26: China Veterinary Oncology Market Revenue (million) Forecast, by Application 2020 & 2033
- Table 27: Japan Veterinary Oncology Market Revenue (million) Forecast, by Application 2020 & 2033
- Table 28: India Veterinary Oncology Market Revenue (million) Forecast, by Application 2020 & 2033
- Table 29: Australia Veterinary Oncology Market Revenue (million) Forecast, by Application 2020 & 2033
- Table 30: South Korea Veterinary Oncology Market Revenue (million) Forecast, by Application 2020 & 2033
- Table 31: Rest of Asia Pacific Veterinary Oncology Market Revenue (million) Forecast, by Application 2020 & 2033
- Table 32: Global Veterinary Oncology Market Revenue million Forecast, by Treatment Type 2020 & 2033
- Table 33: Global Veterinary Oncology Market Revenue million Forecast, by Animal Type 2020 & 2033
- Table 34: Global Veterinary Oncology Market Revenue million Forecast, by Application 2020 & 2033
- Table 35: Global Veterinary Oncology Market Revenue million Forecast, by Country 2020 & 2033
- Table 36: GCC Veterinary Oncology Market Revenue (million) Forecast, by Application 2020 & 2033
- Table 37: South Africa Veterinary Oncology Market Revenue (million) Forecast, by Application 2020 & 2033
- Table 38: Rest of Middle East and Africa Veterinary Oncology Market Revenue (million) Forecast, by Application 2020 & 2033
- Table 39: Global Veterinary Oncology Market Revenue million Forecast, by Treatment Type 2020 & 2033
- Table 40: Global Veterinary Oncology Market Revenue million Forecast, by Animal Type 2020 & 2033
- Table 41: Global Veterinary Oncology Market Revenue million Forecast, by Application 2020 & 2033
- Table 42: Global Veterinary Oncology Market Revenue million Forecast, by Country 2020 & 2033
- Table 43: Brazil Veterinary Oncology Market Revenue (million) Forecast, by Application 2020 & 2033
- Table 44: Argentina Veterinary Oncology Market Revenue (million) Forecast, by Application 2020 & 2033
- Table 45: Rest of South America Veterinary Oncology Market Revenue (million) Forecast, by Application 2020 & 2033
Frequently Asked Questions
1. What is the projected Compound Annual Growth Rate (CAGR) of the Veterinary Oncology Market?
The projected CAGR is approximately 11.8%.
2. Which companies are prominent players in the Veterinary Oncology Market?
Key companies in the market include Morphogenesis Inc, Elanco, OHC (One Health Company), Karyopharm, Siemens Healthineers (Varian Medical System Inc ), Boehringer Ingelheim International GmbH, Accuray Incorporated, Regeneus Ltd, AB Science, Nippon Zenyaku Kogyo Co Ltd (ZENOAQ), PetCure Oncology, Zoetis Inc.
3. What are the main segments of the Veterinary Oncology Market?
The market segments include Treatment Type, Animal Type, Application.
4. Can you provide details about the market size?
The market size is estimated to be USD 810.5 million as of 2022.
5. What are some drivers contributing to market growth?
Rising Prevalence of Cancer Cases in Animals; Increasing Investment on Research and Development in the Area of Veterinary Oncology.
6. What are the notable trends driving market growth?
Canine Animal Type Segment is Expected to Hold a Significant Share in the Market Over the Forecast Period.
7. Are there any restraints impacting market growth?
High Cost of Cancer Treatment and Procedures; Lack of Awareness About Veterinary Diseases Among Owners.
8. Can you provide examples of recent developments in the market?
November 2022: The UW School of Veterinary Medicine received a grant of USD 75,000 to offer life-saving cancer care to pets and their families. The grant will be distributed on a first-come, first-served basis of up to USD 4,000 per client.
9. What pricing options are available for accessing the report?
Pricing options include single-user, multi-user, and enterprise licenses priced at USD 4750, USD 5250, and USD 8750 respectively.
10. Is the market size provided in terms of value or volume?
The market size is provided in terms of value, measured in million.
11. Are there any specific market keywords associated with the report?
Yes, the market keyword associated with the report is "Veterinary Oncology Market," which aids in identifying and referencing the specific market segment covered.
12. How do I determine which pricing option suits my needs best?
The pricing options vary based on user requirements and access needs. Individual users may opt for single-user licenses, while businesses requiring broader access may choose multi-user or enterprise licenses for cost-effective access to the report.
13. Are there any additional resources or data provided in the Veterinary Oncology Market report?
While the report offers comprehensive insights, it's advisable to review the specific contents or supplementary materials provided to ascertain if additional resources or data are available.
14. How can I stay updated on further developments or reports in the Veterinary Oncology Market?
To stay informed about further developments, trends, and reports in the Veterinary Oncology Market, consider subscribing to industry newsletters, following relevant companies and organizations, or regularly checking reputable industry news sources and publications.
Methodology
Step 1 - Identification of Relevant Samples Size from Population Database
Step 2 - Approaches for Defining Global Market Size (Value, Volume* & Price*)
Note*: In applicable scenarios
Step 3 - Data Sources
Primary Research
- Web Analytics
- Survey Reports
- Research Institute
- Latest Research Reports
- Opinion Leaders
Secondary Research
- Annual Reports
- White Paper
- Latest Press Release
- Industry Association
- Paid Database
- Investor Presentations
Step 4 - Data Triangulation
Involves using different sources of information in order to increase the validity of a study
These sources are likely to be stakeholders in a program - participants, other researchers, program staff, other community members, and so on.
Then we put all data in single framework & apply various statistical tools to find out the dynamic on the market.
During the analysis stage, feedback from the stakeholder groups would be compared to determine areas of agreement as well as areas of divergence